2m 2m 2m 2m 2m 2m 2m
Supernus Pharm (SUPN)
NASDAQ
$45.87+$0.02 (+0.04%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.7BMarket Cap
- 2.16%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Supernus Pharm (SUPN)
$45.87+$0.02 (+0.04%)
SUPN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $45.85 | ||
Change | -$1.60 (-3.37%) | ||
Open | $47.71 | ||
High | $47.81 | ||
Low | $45.79 | ||
Previous Close | $47.45 | ||
Volume | 748,894 | ||
30-Day Average Volume | 975,465 | ||
1-Week Change | -5.01% | ||
1-Month Change | -4.22% | ||
1-Year Change | 2.16% | ||
3-Year Change | 46.07% | ||
5-Year Change | 90.33% | ||
Fundamentals | |||
Shares Outstanding | 58.1M | ||
Total Assets | $1.4B | ||
Market Cap | $2.7B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | $165.7M | ||
Net Income | -$58.4M | ||
Free Cash Flow | -$5.4M | ||
EBIT | -$57.6M | ||
EBITDA | -$31.9M | ||
Net Working Capital | $376.1M | ||
EPS | -$1.01 | ||
Enterprise Value/EBITDA | -78 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 3 | ||
P/E | -45 | ||
PEG | 0 | ||
Price/Free Cash Flow | -496 | ||
Price/Operating Cash Flow | -554 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue